TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/09/2025
Voltar para busca
Dado oficial do USPTO
EXELTIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EXELTIS
ST13
US500000079111421Classe
5, 10, 35, 42
Pedido
79111421
Registro
4594815
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
91
Atualização mais recente
24/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 42
Data de depósito
05/03/2012
Data de registro
02/09/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/08/2024
Última transação
24/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Barcelona, ES
Examinador
STRUCK, ROBERT
Localização atual
Historical data usage
Titulares e representantes
Titulares
CHEMO IBERICA, S.A.
CHEMO IBERICA, S.A.
Representantes
Vivian Ortiz-Ponce PEREZ GUERRERO LLC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparation for use in treating * Pharmaceutical preparations for the treatment of ophthalmic diseases and disordersdermatological diseases and disorders* digestive diseases and disordergynecological diseases and disordershormonal diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseases* genitourinary disorders* immunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersneurological diseasespsychiatric diseasescentral nervous system* ; pharmaceutical preparations for the treatment of diseases of the * musculoskeletal system* diseases of the * respiratory systemcirculatory system* circulatory diseases* viral diseasesglaucomadental and oral * mouth * diseasesheadachesmigraineobesityhepatic treatments* treatment of the liver; * cholesterolblood pressure and rheumatic treatments; veterinary preparation for treating digestive diseases and disordergynecological diseases and disordersblood disorderscancercardiovascular diseasesvascular diseasesgastrointestinal diseasesgenitourinary diseasesimmunologic diseasesinfectious diseasesinflammatory diseasesmetabolic diseases and disordersneurological diseasescentral nervous systemmusculoskeletal systemrespiratory systemcirculatory systemviral diseasesglaucomadental and oral diseasesheadachesmigraineobesityhepatic treatmentscholesterolblood pressure and rheumatic treatments; and dietetic foods adapted for medical usebreadspastascrackerschipssnack foodspackaged mealsnutritional food barssweetsdipssauces and food supplements in pillpowdercapsulebeverage formeffervescent tablet and liquid form * ; none of the aforesaid products are preparations in connection with neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease *
Classe 10
Surgical apparatus and instruments; medical instruments for use in gynecological and respiratory disorders; *medical instruments for gynecological disordersophthalmic disordersdermatological disordersmetabolic and respiratory disorders; * orthopedic devices for diagnostic and therapeutic use; suture materials
Classe 35
Sales promotion for third partiesbusiness management assistance; consulting on business management and marketing studies; presentation of goods on communication mediafor retail purposes; business administration of product licenses and services for others; organization of exhibitionstrade fairs or congresses for business or advertising purposesall relating to pharmaceuticalveterinary and biotechnological companies and for pharmaceuticalveterinary and biotechnological products *but none of the aforesaid goods relating to neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease or to goods in the field of neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease *
Classe 42
Chemicalbiological and pharmaceutical research services; engineering * all * none * the aforesaid goods relating to the field of neuroscienceincluding dementiaAlzheimer's disease and Parkinson's disease *
Publicações
Histórico de despachos e eventos da marca no USPTO.
91 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/09/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/09/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
05/07/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/04/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/08/2024
71AG
REGISTERED-SEC.71 ACCEPTED
07/08/2024
ES71
TEAS SECTION 71 RECEIVED
07/08/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
02/09/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
24/03/2022
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
19/09/2021
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
20/08/2021
INPC
INVALIDATION PROCESSED
20/08/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/08/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/12/2020
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
09/12/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2020
ES71
TEAS SECTION 71 RECEIVED
02/09/2020
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/09/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
14/09/2018
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/02/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
26/10/2017
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
26/10/2017
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
23/10/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/10/2017
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
22/09/2017
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
21/09/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
30/03/2017
INPC
INVALIDATION PROCESSED
30/03/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/03/2017
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
01/07/2016
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/07/2016
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
18/12/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
19/12/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/12/2014
FIMP
FINAL DISPOSITION PROCESSED
03/12/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/12/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
02/09/2014
TMBN
TTAB RELEASE CASE TO TRADEMARKS
29/07/2014
OP.T
OPPOSITION TERMINATED NO. 999999
29/07/2014
OP.D
OPPOSITION DISMISSED NO. 999999
29/07/2014
RFNP
REFUSAL PROCESSED BY IB
20/06/2014
IRRF
IRREGULARITY ON REFUSAL FROM IB
19/05/2014
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
08/05/2014
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
06/05/2014
OP.I
OPPOSITION INSTITUTED NO. 999999
10/03/2014
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
24/01/2014
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/12/2013
GPNX
NOTIFICATION PROCESSED BY IB
13/11/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/11/2013
PUBO
PUBLISHED FOR OPPOSITION
12/11/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/10/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/10/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/10/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/10/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/10/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/10/2013
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/10/2013
PBTQ
WITHDRAWN FROM PUB OTQR REQUEST
13/09/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/09/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/08/2013
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
22/08/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/08/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/08/2013
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/08/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/07/2013
ALIE
ASSIGNED TO LIE
23/07/2013
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
22/07/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/07/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/07/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/07/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/01/2013
GNRT
NON-FINAL ACTION E-MAILED
18/01/2013
CNRT
NON-FINAL ACTION WRITTEN
18/01/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/12/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/12/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/12/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/12/2012
RFNT
REFUSAL PROCESSED BY IB
07/07/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/06/2012
RFRR
REFUSAL PROCESSED BY MPU
20/06/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/06/2012
CNRT
NON-FINAL ACTION WRITTEN
19/06/2012
DOCK
ASSIGNED TO EXAMINER
14/06/2012
MAFR
APPLICATION FILING RECEIPT MAILED
01/05/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/04/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/04/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXELTIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.